Horizon Discovery is a UK Biotechnology company that combines a long scientific heritage in translational research with GENESIS™, a precision gene-editing platform that incorporates rAAV, CRISPR and ZFN technologies. The company supplies genetically-defined cell lines, gene-editing tools and services, custom cell line generation, reporter gene assay kits, molecular reference standards and assay development and screening services to approaching 1,000 organizations engaged in academic research; drug discovery and development, clinical diagnostics, and biopharmaceutical process optimization. Horizon aspires to provide science-driven research solutions that lead to the advancement in the understanding of the genetic basis of disease and better outcomes for patients.
Current Team (18)Update
Funding Rounds (5) - $50.2MUpdate
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company...
University of Cambridge Enterprise, also known as Cambridge Enterprise Seed Funds, consisting of...
DFJ Esprit is a Pan-European venture capital fund that invests into disruptive tech companies at...
Life Sciences Investment
7100 Cambridge Research Park
Cambridge, CB25 9TL